P3 Technology

P3 Technology is a biotechnology company focused on the development of next-generation peptide therapeutics using its proprietary Precision Peptide Power (P3T) platform. The company specializes in optimizing the delivery and efficacy of biologics, particularly in the metabolic and endocrine space. Its technology aims to overcome traditional barriers to peptide delivery, such as poor oral bioavailability and short half-life, by engineering peptides with enhanced stability and targeted action. P3 Technology's current research efforts are primarily directed toward developing improved treatments for type 2 diabetes and obesity, leveraging multi-agonist approaches to maximize therapeutic outcomes.